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Ribozymes (catalytic RNAs) were the center of a presumed RNA world in the early origin of life. In this issue,
Lau and Unrau show evidence that an RNA world could have used a similar evolutionary pathway as most
proteins do.
Among our earliest ancestors on earth
were self-replicating RNA systems, ac-
cording to the RNA world hypothesis.
However, direct evidence of these
3billion-year-old RNAorganisms is unlikely
tobefound.Tofindouthowourdistantpast
may have looked, several laboratories are
attempting to recreate an RNA organism
in the laboratory. Although the RNA organ-
isms are still elusive, attempts to recreate
them have taught us some aspects of the
workings of an RNA world. In this issue,
Lau and Unrau (2009) show evidence for
a new evolutionary pathway that could
have helped shape the RNA world.
There are three evolu-
tionary pathways that can
generate new ribozyme activ-
ities: (I) denovo froma random
sequence, (II) from an existing
ribozyme by changing its
global structure, or (III) from
an existing ribozyme bymain-
taining its global structure
(Figure 1).
The first pathway would
have been most important
in the beginning of the
RNA world, where ribozymes
would have to appear de novo
from more or less random
sequences. The likelihood of
these events depends on the
information content of each
ribozyme. An example for a
small ribozyme is the recently
discovered aminoacylating
ribozyme with three con-
served nucleotides (Chuma-
chenko et al., 2009); this
ribozyme would have been
a frequent guest in an RNA
world. However, each bit of
sequence information makes
the appearance of a larger
ribozyme less and less likely
(Carothers et al., 2004). An example for
a medium-sized ribozyme is the class I
ligase with 92 nucleotides. This ribozyme
would appear only once in 3 x 1018 mole-
cules of 220-nucleotide random RNA
sequence (Ekland et al., 1995). Low prob-
abilities like these present a major hurdle
for many ribozymes to appear in an RNA
world.
The second evolutionary pathway
describes how an existing ribozyme
evolves a different catalytic activity, with
the parent and daughter ribozymes having
completelydifferent folds.Suchapathway
was shown to exist by engineering all
evolutionary intermediates between the
self-cleaving HDV ribozyme and the class
III self-ligating ribozyme (Schultes and
Bartel, 2000). All of their evolutionary inter-
mediates have either one fold and the cor-
responding catalytic activity, or the other
fold with its corresponding activity. The
intersection sequence can assume both
folds. While this study showed that the
pathway exists, a different study showed
that this pathway is actually used by
ribozymes; when an aminoacylase ribo-
zymewas challenged to evolve into kinase
ribozymes, the daughter ribozymes
escaped the parent fold (Curtis andBartel,
2005). RNA seems predes-
tined to switch its global fold
during evolution because
most RNA sequences can
fold into stable structures
(Schultes et al., 2005). In other
words, a given parental
sequence has many evolu-
tionary neighbors that contain
a different catalytic activity
but most of them fold into
different global structures.
This explains why at least
some ribozymes prefer to
escape their parental fold
during evolution.
In the third pathway, a new
ribozyme activity is generated
from an existing ribozyme but
the daughter ribozyme main-
tains the fold of the parent
ribozyme. This evolutionary
behavior has been known
for proteins (Soding and
Lupas, 2003): catalytic pro-
miscuity allows the parent
protein to catalyze a second
reaction to a low extent, then
evolution can improve the
efficiency of this second acti-
vity (O’Brien and Herschlag,
Figure 1. Three Evolutionary Pathways to Generate New Ribozymes
(I) De novo appearance: ribozymes can originate from random sequences, by
amplification of the fittest.
(II) Escaping the parents: when new ribozyme activities evolve from an existing
ribozyme, they tend to prefer a new global fold.
(III) Staying with the parent fold: in this issue, Lau and Unrau (2009) describe
a ribozyme that could act as an evolutionary link between parent and daughter
ribozymes that have maintained the same fold. Colors and letters are used to
illustrate evolutionary transitions on the level of structure and sequence.
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1999). However, the only example of a
ribozyme that indicates such an evolu-
tionary path is the self-splicing group I
intron, which is able to catalyze several
closely related reactions (Forconi and
Herschlag, 2005). A ribozyme was now
found that catalyzes two very different
reaction chemistries, both of which are
coupling ribose and guanine covalently
(Lau and Unrau, 2009). One reaction
creates the N-glycosidic bond as seen in
today’s nucleotides, the other creates
a stable connection via Schiff base
chemistry and Amadori rearrangement.
Therefore, this ribozyme could act as an
evolutionary intermediate between two
ribozymes, each specific for one reaction.
Because this ribozyme probably has the
same global fold for both catalytic activi-
ties, it is the best available evidence for
ribozyme evolution via the third pathway.
Future research may elucidate the evolu-
tionary neighbors of this intersection
sequence, and in vitro selection experi-
ments could show that this evolutionary
pathway actually takes place.
In contrast to RNAs, protein enzymes
appear unable or unlikely to walk the
first or the second evolutionary pathway
because only very few amino acid
sequences specify a stable fold. There-
fore, the first peptides probably evolved
using the third pathway by building
onto an RNA scaffold before being able
to fold independently (Soding and Lu-
pas, 2003). Later evolutionary steps
would have used these independently
folding protein scaffolds to develop new
catalytic activities (Seelig and Szostak,
2007).
Which of the pathways would have
been dominant in an RNA world?
Currently, the numbers of identified ribo-
zymes are on the side of ‘‘escaping the
parent fold’’ (Curtis and Bartel, 2005).
However, the discovery of the promis-
cuous nucleotide synthase ribozyme
(Lau and Unrau, 2009) shows that this
picture is still emerging. Further in vitro
evolution experiments are needed to
determine when a ribozyme follows
a specific evolutionary pathway. For
example, the evolutionary decision could
hinge on the reaction mechanisms or the
evolutionary plasticity of an RNA struc-
ture. However, only after self-replicating
and evolving ribozyme systems are found
(Lincoln and Joyce, 2009) that are
capable of generating ribozymes with
new activities will we be able to pose
these burning questions face-to-face
with our strange RNA ancestors.
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In this issue, Kamisuki and colleagues characterize fatostatin. This compound inhibits the activity of SREBPs,
the master transcription factors of lipid homeostasis. This useful laboratory tool also improved the lipid
profile of obese mice; does this have clinical implications?
Obesity is a growth industry, with no
prospect of downsizing anytime soon.
Associated with cardiovascular disease,
hypertension, and diabetes, obesity has
become a major health burden in the
developed world and is becoming an in-
creasingly prominent issue in developing
countries aswell. Despite the stigma often
attached to lipids in the public conscious-
ness, they are crucial for growth and
development. For instance, fatty acids
and cholesterol are essential for the
synthesis of cell membranes and various
signaling molecules.
At the molecular level, lipid levels are
tightly regulated by the family of sterol-
regulatory element binding proteins
(SREBPs) (Goldstein et al., 2006). These
transcription factors initially reside in
the endoplasmic reticulum (ER), tethered
to SREBP cleavage activating protein
(SCAP). SCAPescorts SREBP to theGolgi
apparatus, where SREBP is processed by
site-1-protease (S1P) and site-2-protease
(S2P) (Figure 1A). This releases themature
form of SREBP, which migrates into the
nucleus to target the genes involved in
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